Venus Remedies achieves the EU GMP renewal from Infarmed, underscoring its precision-driven manufacturing practices. This achievement boosts its advancement in Europe, paving the way for wider market integration and competitive edge throughout the region.

Venus Remedies expands its global footprint as the Philippines grants marketing approval for Sugammadex, a breakthrough anesthetic reversal drug.